Brief: Armata Pharmaceuticals Announces Development Of New Synthetic Phage Candidate Targeting Pseudomonas Aeruginosa
12/09/2019 14:16
Sept 12 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES DEVELOPMENT OF NEW
SYNTHETIC
PHAGE CANDIDATE TARGETING PSEUDOMONAS AERUGINOSA
Source text for Eikon: ID:nPnc2L7kqa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles